4-氟苯乙酮合成路线

Penning, Thomas D.; Talley, John J.; Bertenshaw, Stephen R.; Carter, Jeffery S.; Collins, Paul W.; Docter, Stephen; Graneto, Matthew J.; Lee, Len F.; Malecha, James W.; Miyashiro, Julie M.; Rogers, Roland S.; Rogier; Yu, Stella S.; Anderson, Gary D.; Burton, Earl G.; Cogburn, J. Nita; Gregory, Susan A.; Koboldt, Carol M.; Perkins, William E.; Seibert, Karen; Veenhuizen, Amy W.; Zhang, Yan Y.; Isakson, Peter C.
Journal of Medicinal Chemistry, 1997 , vol. 40, # 9 p. 1347 - 1365

403-42-94-氟苯乙酮

39758-40-2

参考文献

Baboulene,M. et al.
Chimica Therapeutica, 1972 , vol. 7, p. 493 - 502

403-42-94-氟苯乙酮+

106-48-9对氯苯酚

41150-48-54-(4-氯苯氧基)苯乙酮

参考文献

Han, Young Taek; Kim, Kyeojin; Choi, Gyeong-In; An, Hongchan; Son, Dohyun; Kim, Hee; Ha, Hee-Jin; Son, Jun-Hyeng; Chung, Suk-Jae; Park, Hyun-Ju; Lee, Jeewoo; Suh, Young-Ger
European Journal of Medicinal Chemistry, 2014 , vol. 79, p. 128 - 142

506-59-2盐酸二甲胺+

403-42-94-氟苯乙酮

3935-51-1

参考文献

Novo Nordisk A/S
Patent: US5145870 A1, 1992 ;

参考文献

Kucukoglu, Kaan; Gul, Mustafa; Atalay, Mustafa; Mete, Ebru; Kazaz, Cavit; Hanninen, Osmo; Gul, Halise Inci
Arzneimittel-Forschung/Drug Research, 2011 , vol. 61, # 6 p. 366 - 371

参考文献

GLAXO GROUP LIMITED
Patent: WO2004/72069 A1, 2004 ;
Location in patent: Page 17 ;
WO 2004/072069 A1